These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35065017)
1. SMFM Consult Series #58: Need for a clear evidence base to guide expanded use of antenatal corticosteroids for individuals at risk for late preterm delivery. Vidaeff AC; Shamshirsaz AA; Aagaard KM Am J Obstet Gynecol; 2022 Jun; 226(6):876-877. PubMed ID: 35065017 [No Abstract] [Full Text] [Related]
2. The efficacy of antenatal corticosteroids to improve preterm newborn outcomes in low-resource countries: Are we there yet? Sultana S; Vogel JP; Oladapo OT BJOG; 2023 Nov; 130 Suppl 3():84-91. PubMed ID: 37530472 [No Abstract] [Full Text] [Related]
3. Antenatal corticosteroids administration and threatened preterm birth: could "wait and see" represent the optimal management in selected cases? Dall'Asta A; Ghi T Am J Obstet Gynecol; 2022 May; 226(5):752-753. PubMed ID: 34896315 [No Abstract] [Full Text] [Related]
4. The Benefit-Risk Ratio of Late Preterm Antenatal Corticosteroids Could Be Unfavorable in Real-life Situations. Schmitz T; Sénat MV; Sentilhes L JAMA Pediatr; 2023 Mar; 177(3):320-321. PubMed ID: 36622655 [No Abstract] [Full Text] [Related]
5. Antenatal Corticosteroids: Who Should We Be Treating? Booker WA; Gyamfi-Bannerman C Clin Perinatol; 2018 Jun; 45(2):181-198. PubMed ID: 29747882 [TBL] [Abstract][Full Text] [Related]
6. Controversies in antenatal corticosteroid treatment. Thevathasan I; Said JM Prenat Diagn; 2020 Aug; 40(9):1138-1149. PubMed ID: 32157719 [TBL] [Abstract][Full Text] [Related]
7. A dilemma of antenatal corticosteroids for long-term consequences. Yang Y; Li DZ Am J Obstet Gynecol; 2023 Jan; 228(1):115-116. PubMed ID: 36041547 [No Abstract] [Full Text] [Related]
8. Antenatal corticosteroids for the late preterm infant and agnotology. Kaempf JW; Suresh G J Perinatol; 2017 Dec; 37(12):1265-1267. PubMed ID: 29192694 [No Abstract] [Full Text] [Related]
9. Society for Maternal-Fetal Medicine Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preterm delivery: a response. Society for Maternal-Fetal Medicine, Publications Committee. Electronic address: pubs@smfm.org Am J Obstet Gynecol; 2022 Jun; 226(6):877. PubMed ID: 35085540 [No Abstract] [Full Text] [Related]
10. The Benefit-Risk Ratio of Late Preterm Antenatal Corticosteroids Could Be Unfavorable in Real-life Situations-Reply. Freret TS; Clapp MA JAMA Pediatr; 2023 Mar; 177(3):321-322. PubMed ID: 36622670 [No Abstract] [Full Text] [Related]
11. Time interval from late preterm antenatal corticosteroid administration to delivery and the impact on neonatal outcomes. Gulersen M; Gyamfi-Bannerman C; Greenman M; Lenchner E; Rochelson B; Bornstein E Am J Obstet Gynecol MFM; 2021 Sep; 3(5):100426. PubMed ID: 34153514 [TBL] [Abstract][Full Text] [Related]
12. Antenatal corticosteroids in the late preterm period: A prospective cohort study. Ramadan MK; Hussein G; Saheb W; Rajab M; Mirza FG J Neonatal Perinatal Med; 2016; 9(1):15-22. PubMed ID: 27002271 [TBL] [Abstract][Full Text] [Related]
13. Updating the balance between benefits and harms of antenatal corticosteroids. Vidaeff AC; Belfort MA; Kemp MW; Saade GR; Caughey AB; Wapner RJ; Goldenberg RL; Jobe AH Am J Obstet Gynecol; 2023 Feb; 228(2):129-132. PubMed ID: 36396484 [No Abstract] [Full Text] [Related]
14. Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation. Mori R; Kusuda S; Fujimura M; J Pediatr; 2011 Jul; 159(1):110-114.e1. PubMed ID: 21334006 [TBL] [Abstract][Full Text] [Related]